Joseph Ragaz

11.5k total citations · 3 hit papers
69 papers, 5.6k citations indexed

About

Joseph Ragaz is a scholar working on Cancer Research, Oncology and Genetics. According to data from OpenAlex, Joseph Ragaz has authored 69 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Cancer Research, 33 papers in Oncology and 16 papers in Genetics. Recurrent topics in Joseph Ragaz's work include Breast Cancer Treatment Studies (39 papers), Cancer Treatment and Pharmacology (14 papers) and Estrogen and related hormone effects (11 papers). Joseph Ragaz is often cited by papers focused on Breast Cancer Treatment Studies (39 papers), Cancer Treatment and Pharmacology (14 papers) and Estrogen and related hormone effects (11 papers). Joseph Ragaz collaborates with scholars based in Canada, United States and China. Joseph Ragaz's co-authors include Ivo A. Olivotto, C Coppin, Kenneth S. Wilson, Stewart M. Jackson, John J. Spinelli, Nhu Le, Torsten O. Nielsen, Forrest D. Hsu, Maggie C.U. Cheang and C. Blake Gilks and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Joseph Ragaz

67 papers receiving 5.4k citations

Hit Papers

Immunohistochemical and Clinical Characterization of the ... 1997 2026 2006 2016 2004 1997 2005 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
    2004 2.1k citations Joseph Ragaz et al. profile →
  2. Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast Cancer
    1997 1.3k citations Joseph Ragaz, Stewart M. Jackson et al. New England Journal of Medicine profile →
  3. Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized Trial
    2005 757 citations Joseph Ragaz, Ivo A. Olivotto et al. JNCI Journal of the National Cancer Institute profile →

Peers

Joseph Ragaz
Gordon F. Schwartz United States
Mauro G. Mastropasqua Italy
Caroline Speers Canada
Milvia Zambetti Italy
A. Marilyn Leitch United States
Philippe Rouanet France
R. Douglas Macmillan United Kingdom
Hideo Inaji Japan
Aron Goldhirsch Italy
Futoshi Akiyama Japan
Gordon F. Schwartz United States
Joseph Ragaz
Citations per year, relative to Joseph Ragaz Joseph Ragaz (= 1×) peers Gordon F. Schwartz

Countries citing papers authored by Joseph Ragaz

Since Specialization
Citations

This map shows the geographic impact of Joseph Ragaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Ragaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Ragaz more than expected).

Fields of papers citing papers by Joseph Ragaz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Ragaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Ragaz. The network helps show where Joseph Ragaz may publish in the future.

Co-authorship network of co-authors of Joseph Ragaz

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Ragaz. A scholar is included among the top collaborators of Joseph Ragaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Ragaz. Joseph Ragaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Ting, Biyun Wang, Zhonghua Wang, et al.. (2015). Bevacizumab in Combination with Modified FOLFOX6 in Heavily Pretreated Patients with HER2/Neu-Negative Metastatic Breast Cancer: A Phase II Clinical Trial. PLoS ONE. 10(7). e0133133–e0133133. 6 indexed citations
3.
Zhang, Jian, Zhenyu Jia, Joseph Ragaz, et al.. (2013). The maximum standardized uptake value of 18 F-FDG PET scan to determine prognosis of hormone-receptor positive metastatic breast cancer. BMC Cancer. 13(1). 42–42. 29 indexed citations
4.
Zhang, Jian, Zhenyu Jia, Min Zhou, et al.. (2013). The SUVmax for 18F-FDG Correlates With Molecular Subtype and Survival of Previously Untreated Metastatic Breast Cancer. Clinical Nuclear Medicine. 38(4). 256–262. 13 indexed citations
5.
Ragaz, Joseph. (2010). Randomized adjuvant trials in oncology: a necessity or time-consuming luxury?. Breast Cancer Research. 12(S4). S14–S14.
6.
Ragaz, Joseph. (2009). Radiation impact in breast cancer. Breast Cancer Research. 11(S3). S14–S14. 8 indexed citations
7.
Mackey, John R., Deanna McLeod, Joseph Ragaz, et al.. (2009). Adjuvant targeted therapy in early breast cancer. Cancer. 115(6). 1154–1168. 29 indexed citations
8.
9.
Long, Brian J., Danijela Jelovac, Venkatesh Handratta, et al.. (2004). Therapeutic Strategies Using the Aromatase Inhibitor Letrozole and Tamoxifen in a Breast Cancer Model. JNCI Journal of the National Cancer Institute. 96(6). 456–465. 102 indexed citations
10.
Chua, Boon, Ivo A. Olivotto, Lorna Weir, et al.. (2004). Increased Use of Adjuvant Regional Radiotherapy for Node-Positive Breast Cancer in British Columbia. The Breast Journal. 10(1). 38–44. 20 indexed citations
11.
Ragaz, Joseph. (2001). Adjuvant trials of aromatase inhibitors: determining the future landscape of adjuvant endocrine therapy. The Journal of Steroid Biochemistry and Molecular Biology. 79(1-5). 133–141. 6 indexed citations
12.
Olivotto, Ivo A., Jeremy S. H. Jackson, Donna Mates, et al.. (1998). Prediction of axillary lymph node involvement of women with invasive breast carcinoma. Cancer. 83(5). 948–955. 108 indexed citations
13.
Olivotto, Ivo A., Jeremy S. H. Jackson, Donna Mates, et al.. (1998). Prediction of axillary lymph node involvement of women with invasive breast carcinoma. Cancer. 83(5). 948–955. 3 indexed citations
14.
15.
Gelmon, Karen A., Anthony W. Tolcher, Séamus O’Reilly, et al.. (1998). A phase I–II study of bi-weekly paclitaxel as first-line treatment in metastatic breast cancer. Annals of Oncology. 9(11). 1247–1249. 9 indexed citations
16.
Gelmon, Karen A., Sean OʼReilly, Anthony W. Tolcher, et al.. (1996). Phase I/II trial of biweekly paclitaxel and cisplatin in the treatment of metastatic breast cancer.. Journal of Clinical Oncology. 14(4). 1185–1191. 54 indexed citations
17.
Olivotto, Ivo A., Chris Bajdik, Ian H. Plenderleith, et al.. (1994). Adjuvant Systemic Therapy and Survival after Breast Cancer. New England Journal of Medicine. 330(12). 805–810. 64 indexed citations
18.
Ragaz, Joseph, et al.. (1989). Experimental Basis and Clinical Reality of Preoperative (Neoadjuvant) Chemotherapy in Breast Cancer. Recent results in cancer research. 115. 28–35. 7 indexed citations
19.
Scudamore, Charles H., et al.. (1988). Hepatocellular carcinoma. The American Journal of Surgery. 155(5). 659–662. 39 indexed citations
20.
Ragaz, Joseph, et al.. (1985). Neoadjuvant (preoperative) chemotherapy for breast cancer. Cancer. 56(4). 719–724. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gordon F. Schwartz Breakdown of academic impact, for papers by Mauro G. Mastropasqua Breakdown of academic impact, for papers by Caroline Speers Breakdown of academic impact, for papers by Milvia Zambetti Breakdown of academic impact, for papers by A. Marilyn Leitch Breakdown of academic impact, for papers by Philippe Rouanet Breakdown of academic impact, for papers by R. Douglas Macmillan Breakdown of academic impact, for papers by Hideo Inaji Breakdown of academic impact, for papers by Aron Goldhirsch Breakdown of academic impact, for papers by Futoshi Akiyama
Rankless by CCL
2026